Evidence map›Paper›PMID 40225434›Full record

ArticleCureus2025

Acetazolamide-Induced Liver Injury: A Case Report and Literature Review.

Aabid Mohiuddin, Fawaz Hussain, Ali Al-Ramadan, Kirthi K Lilley

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aabid MohiuddinDepartment of Internal Medicine, Detroit Medical Center/Wayne State University, Detroit, USA.
Fawaz HussainDepartment of Internal Medicine, Detroit Medical Center/Wayne State University, Detroit, USA.
Ali Al-RamadanDepartment of Internal Medicine, Detroit Medical Center/Wayne State University, Detroit, USA.
Kirthi K LilleyDepartment of Gastroenterology, Wayne State University School of Medicine, Detroit, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetazolamide is a carbonic anhydrase inhibitor, which has been very rarely associated with drug-induced liver injury (DILI). This report presents a case of an elderly male who developed severe but asymptomatic DILI associated with acetazolamide use. Severity was established based on markedly elevated serum transaminases. Subsequent rechallenge of acetazolamide at a higher dose resulted in increased severity of the elevations, further suggesting a causative effect. Liver function tests ultimately improved after acetazolamide discontinuation. This case underscores the need for early recognition and timely discontinuation of acetazolamide to prevent worsening liver injury and optimize clinical outcomes. Only two prior documented cases of acetazolamide-induced DILI are found in the medical literature. A detailed review and comparison of those prior cases have been undertaken in the discussion of this case presentation.

Indexed as

acetazolamidecarbonic anhydrase inhibitordilidrug-induced liver injuryhepatotoxicity

Identifiers

PMID40225434
PMCPMC11993354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.